Optimizing outcomes by preconditioning the donor

Transplantation Proceedings

Volumn 43, Issue 1, 2011, Pages 349-352

  Lledo Garcia E ^a   Subira Rios D ^a   Tejedor Jorge, A ^a   Del Canizo Lopez J F ^a   Hernandez Fernandez C ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CADAVER KIDNEY; COLD ISCHEMIA; COMORBIDITY; CONFERENCE PAPER; DONOR SELECTION; HEART DEATH; HUMAN; KIDNEY BIOPSY; KIDNEY DONOR; LIVING DONOR; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION; SURVIVAL;

CADAVER; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 79951788007     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.12.020     Document Type: Conference Paper

References (17)

1. Kälble T, Lucan M, Nicita G, et al: EAU guidelines on renal transplantation. European Urology 47:156, 2005
2. Sellers MT, Velidedeoglu E, Bloom RD, et al: NHS Economic Evaluation Database (NHS EED). Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis - cause for concern in retransplantation. NHS Economic Evaluation Database (NHS EED). Produced by the Centre for Reviews and Dissemination
3. Knoll G, et al: Trends in kidney transplantation over the past decade. Drugs 68(suppl 1):3, 2008
4. Salahudeen AK: Cold ischemic injury of transplanted kidneys: new insights from experimental studies. Am J Physiol Renal Physiol 287:F181, 2004
5. Salahudeen AK, May W: Reduction in cold ischemia time of renal allografts in the United States over the last decade. Transplant Proc 40:1285, 2008
6. Goh CC, Ladouceur M, Peters L, et al: Lengthy cold ischemia time is a modifiable risk factor associated with low glomerular filtration rates in expanded criteria donor kidney transplant recipients. Transplant Proc 41:3290, 2009
7. Pasupathy S: Ischemic preconditioning protects against ischemia-reperfusion injury: emerging concepts. Eur J Vasc Endovasc Surg 29:106, 2005
8. Karbanda RK, et al: Translation of remote ischemic preconditioning into clinical practice. Lancet 374:1557, 2009
9. Zhao ZQ, Corvera JS, Halkos ME, et al: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285:H579, 2003
10. Huang Y: Can ischemic preconditioning alone really protect organs from ischemia reperfusion injury in transplantation. Transplant Immunol 20:127, 2009
11. Guan X, et al: Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation. J Surg Res 146:127, 2008
12. Fuller TF, et al: Glutamine donor pretreatment in rat kidney transplants with severe preservation reperfusion injury. J Surg Res 140:77, 2007
13. Otean M, et al: Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in rats. Surgery 141:667, 2007
14. Kukreja RC: Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vascul Pharmacol 42:219, 2005
15. Lledó-García E, Subirá-Ríos D, Rodríguez D, et al: Sildenafil as a protecting drug for warm ischemic kidney transplants: experimental results. J Urol 182:1222, 2009
16. Moore DJ, Markmann JF, Deng S: Avenues for immunomodulation and graft protection by gene therapy in transplantation. Transpl Int 19:435, 2006
17. Ritter, Kupiec-Weglinski JW: Gene therapy for the prevention of ischemia/reperfusion injury in organ transplantation. Curr Gene Ther 5:101, 2005